Share Name Share Symbol Market Type Share ISIN Share Description
Bespak Plc LSE:BPK London Ordinary Share GB0000946276 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 667.00p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 126.5 15.7 34.8 19.2 0.00

Bespak (BPK) Latest News

Real-Time news about Bespak (London Stock Exchange): 0 recent articles
More Bespak News
Bespak Takeover Rumours

Bespak (BPK) Share Charts

1 Year Bespak Chart

1 Year Bespak Chart

1 Month Bespak Chart

1 Month Bespak Chart

Intraday Bespak Chart

Intraday Bespak Chart

Bespak (BPK) Discussions and Chat

Bespak Forums and Chat

Date Time Title Posts
20/6/200720:59Director buying at Bespak..have we reached the bottom?127.00
28/2/200211:25short sale1.00

Add a New Thread

Bespak (BPK) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Bespak trades in real-time

Bespak (BPK) Top Chat Posts

DateSubject
05/3/2004
08:59
grupo guitarlumber: (Repeating to clarify nature of deal, adds share price other background) LONDON (AFX) - Bespak PLC said the European Medicines Evaluation Agency had accepted a filing by Pfizer Inc and Aventis SA who are both seeking rights to market Exubera, a diabetes treatment which is inhaled in powdered form. Bespak said it will manufacture the drug delivery device under an arrangement with Nektar Therapeutics, Inc, a US company which developed both Exubera and the means of delivering it. In a statement, Bespak said the timing of full scale production is as yet unknown and will depend in part on the speed of the regulatory review process. Pfizer and Aventis are seeking approval to market Exubera to adult patients with Type 1 and Type 2 diabetes. At 8.20 am Bespak was among the best performing small-cap stocks in the London market, gaining 22-1/2 pence, or 4.2 pct, to 557-1/2. rhb/rn
06/4/2002
11:33
daycase1: * Medical devices company Bespak’s (BPK) non-executive director William Meredith has been shopping on the other side of the Atlantic as he picked up 5,000 American Depository Receipts on Wednesday at $7.50 (523p). His £26,130 payout doubles his holding in the company to 10,000 ADRs. Meredith has pounced while Bespak’s share price is struggling close to its year-low. It began the year in sprightly fashion at a high of 590p but fell gradually until it hit 500p last week. After a brief rally it has stalled and today closed down 1p at 504p. In January the company reported record sales in the six months to 2 November of £42.9 million, up from £40.4 million the previous year. However pre-tax profits slipped from £7.8 million to £7.2 million after higher research and development costs.
Bespak share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20161211 08:01:35